Active substance
Bilastine
- SFDA 4
- Health Canada 13
- NHS prices 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| BILAXTEN 20MG TABLET | 20 mg | Tablet · Oral use | 20 Blister | SAR 29.75 | NCE · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| BILAZAP | 20 mg | Tablet · Oral use | 20 Blister | SAR 20.80 | Generic · Prescription | ALPHA PHARMA INDUSTRY | Valid |
| Bilaxten | 2.5 mg/ml | Oral solution · Oral use | 1 Bottle | SAR 26.75 | NCE · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| Bilaxten | 10 mg | Orodispersible tablet · Oral use | 30 Blister | SAR 26.75 | NCE · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
Indications — CHI Daman Drug Formulary
ALLERGIC CONJUCTIVITIS (AC); ALLERGIC RHINITIS; HUMAN IMMUNODEFICIENCY VIRUS; TUBERCULOSIS-SUPPORTIVE CARE
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APO-BILASTINE TABLETS | 02549883 | 20 MG | TABLET · ORAL | APOTEX INC |
| AURO-BILASTINE | 02541556 | 20 MG | TABLET · ORAL | AURO PHARMA INC |
| BLEXTEN | 02454130 | 20 MG | TABLET · ORAL | ARALEZ PHARMACEUTICALS CANADA INC |
| BLEXTEN | 02519011 | 2.5 MG / ML | SOLUTION · ORAL | ARALEZ PHARMACEUTICALS CANADA INC |
| BLEXTEN | 02519038 | 10 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | ARALEZ PHARMACEUTICALS CANADA INC |
| GLN-BILASTINE | 02544369 | 20 MG | TABLET · ORAL | GLENMARK PHARMACEUTICALS CANADA INC. |
| JAMP BILASTINE | 02546795 | 20 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| JAMP BILASTINE ORAL SOLUTION | 02448262 | 2.5 MG / ML | SOLUTION · ORAL | JAMP PHARMA CORPORATION |
| M-BILASTINE | 02548410 | 20 MG | TABLET · ORAL | MANTRA PHARMA INC |
| MAR-BILASTINE | 02547279 | 20 MG | TABLET · ORAL | MARCAN PHARMACEUTICALS INC |
| NRA-BILASTINE | 02551934 | 20 MG | TABLET · ORAL | NORA PHARMA INC |
| PMS-BILASTINE | 02561565 | 20 MG | TABLET · ORAL | PHARMASCIENCE INC |
| SANDOZ BILASTINE | 02536269 | 20 MG | TABLET · ORAL | SANDOZ CANADA INCORPORATED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Bilastine 20mg tablets | £6.00 | 30 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.